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SUMMARY 
The Pold3 gene encodes a subunit of the Polδ DNA polymerase complex. 
Pold3 orthologues are not essential in Saccharomyces cerevisiae or chicken 
DT40 cells, but the Schizzosaccharomyces pombe orthologue is essential. 
POLD3 also has a specialized role in the repair of broken replication forks, 
suggesting that POLD3 activity could be particularly relevant for cancer cells 
enduring high levels of DNA replication stress. We report here that POLD3 is 
essential for mouse development and is also required for viability in adult 
animals. Strikingly, even Pold3+/- mice were born at sub-Mendelian ratios and, 
of those born, some presented hydrocephaly and had a reduced lifespan. In 
cells, POLD3 deficiency led to replication stress and cell death, which were 
aggravated by expression of activated oncogenes. Finally, we show that Pold3 
deletion destabilizes all members of the Polδ complex, explaining its major role 
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INTRODUCTION 
The bulk of DNA replication in eukaryotes is carried by two major DNA 
polymerase complexes, Polδ and Polε, in charge of replicating the lagging and 
leading strands, respectively (Johansson and Dixon, 2013). Each complex 
contains several subunits, whose roles are not completely defined. The Polδ 
complex was originally isolated as a dimer of p125 (POLD1) and p50 (POLD2) 
with POLD1 bearing the polymerase catalytic activity and POLD2 serving an 
essential structural role (Lee et al., 1984; Ng et al., 1991). Later studies 
identified two additional subunits (POLD3 and POLD4), which in vitro stimulated 
the catalytic activity of the complex (Hughes et al., 1999; Liu et al., 2000; Mo et 
al., 2000). Recent studies in yeast and mammals have attracted specific 
attention onto POLD3 (Pol32, in S. cerevisiae), since it has been shown to 
regulate the repair of broken replication forks through break-induced replication 
(BIR) and to promote repair-associated DNA synthesis in mitosis, pathways that 
might be particularly relevant in the context of replication stress (RS) and 
therefore for cancer cells (Costantino et al., 2014; Lydeard et al., 2007; Mayle et 
al., 2015; Minocherhomji et al., 2015).  
 
POLD3 was first isolated from calf thymus, and shown to have two important 
roles within the POLD complex. It stabilizes the POLD1-POLD2 interaction and, 
through a C-terminal PIP box, it facilitates the interaction of the POLD complex 
with PCNA (Ducoux et al., 2001; Shikata et al., 2001). In addition, POLD3 is 
necessary for the recruitment of POLD1 to sites of UV-light induced DNA 
damage (Ogi et al., 2010). Moreover, POLD3 presents additional functions that 
are independent of genome duplication during S-phase. First, a complex of 
POLD3-POLD2 interacts with Rev3 and Rev7, increasing the activity of the 
translesion (TLS) polymerase Pol ζ  (Lee et al., 2014). Deletion of the chicken 
POLD3 orthologue in DT40 cells further supported a role in TLS (Hirota et al., 
2015). And second, a recent study described that POLD3 is essential for BIR in 
human cells, a pathway that is particularly important for cancer cells (Costantino 
et al., 2014). However, to what extent POLD3 is essential for normal cells is still 
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unclear. In S. cerevisiae, where the Polδ complex is only made of 3 subunits 
(Pol3: POLD1; Pol31: POLD2; Pol32: POLD3), deletion of the POLD3 
orthologue Pol32 is not lethal, but sensitizes cells to replication challenges such 
as hydroxyurea (HU) or alkylating agents (Gerik et al., 1998). However, the 
POLD3 orthologue Cdc27 is essential in S. pombe, where the Polδ complex is 
built of 4 subunits (Pol3: POLD1; Cdc1: POLD2; Cdc27: POLD3; Cdm1: 
POLD4) (MacNeill et al., 1996; Zuo et al., 1997). Nevertheless, POLD3 is not 
essential for chicken DT40 cells, and human cells tolerate its depletion by 
siRNA (Costantino et al., 2014; Hirota et al., 2015). 
 
Given the growing interest on POLD3, we here sought to clarify whether it is 
essential in mammalian cells, and to specifically interrogate how an acute 
depletion of POLD3 impacts the Polδ complex. By developing a conditional 
knockout strain, we found that POLD3 is essential in mice both during 
embryonic development but also when deleted postnatally. Furthermore, Pold3 
heterozygous mice are born at sub-Mendelian ratios and present a reduced 
lifespan. These severe phenotypes are mechanistically explained by the 
discovery that the absence of POLD3 destabilizes all members of the Polδ 
complex, which leads to a severe replication defect and widespread replication 
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RESULTS  
POLD3 is essential for mouse development 
To investigate the physiological roles of POLD3 we generated a conditional 
knockout (cKO) strain by using a gene-trap targeting construct that can be 
converted into a cKO vector (Pold3GT:lox; see Methods) (Figure 1A). Southern 
blot analysis confirmed the correct integration of the targeting construct in 
embryonic stem (ES) cells (Figure 1B), from which mouse chimaeras were 
subsequently generated. After verifying the transmission of the mutant allele by 
PCR, we crossed the strain with mice that ubiquitously express the FLP 
recombinase from the β-ACTIN promoter (Rodriguez et al., 2000). This 
eliminated the gene-trap and neomycin resistance cassette and led to the 
generation of the Pold3 cKO strain (Pold3lox). 
To determine whether POLD3 is essential in mice, we crossed Pold3lox/+ mice 
with an EIIA-Cre strain that ubiquitously expresses the Cre recombinase (Lakso 
et al., 1996). This generated mice heterozygous for a Pold3 null allele. Pold3+/- 
mice were subsequently inter-crossed to explore whether POLD3-deficient mice 
could be born. Out of 334 mice born from heterozygous crosses, no Pold3-/- 
mice were obtained. We also failed to obtain Pold3-knockout mouse embryo 
fibroblasts (MEFs) as early as 10.5 dpc. Strikingly, only 62% of the Pold3 
heterozygous animals expected from a homozygous-lethal cross were born 
(185 out of 298; Figure 1C). Moreover, 11% of the Pold3+/- mice that were born 
died prematurely within the first 10 weeks (Figure 1D). Pold3 heterozygous 
mice that died prematurely were dwarf from birth and presented an enlarged 
skull size reminiscent of hydrocephaly (Figure 1E). Pathological analyses 
confirmed this diagnosis, which was most evident in moribund mice and thus, 
likely causative of their death (Figure 1E,F). The fact that the phenotype was 
more penetrant in a fraction of the mice and the preferential targeting of the 
brain are reminiscent of syndromes associated with embryonic replication stress 
(RS), such as, for example, the Seckel syndrome, caused by reduced levels of 
the ATR kinase (Murga et al., 2009). Given that brain development is dependent 
on rapid cell proliferation at specific developmental stages, genetic defects that 
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limit the capacity for DNA replication, such as Pold3 heterozygosity or Atr 
hypomorphism, would render brain development very sensitive to any factor, 
environmental or genetic, that further compromises cell proliferation during 
critical developmental stages.  
 
Pold3 deletion leads to lethality in adult mice 
To further investigate the physiological consequences of Pold3 deletion, we 
used a previously developed transgenic strain that ubiquitously expresses a 
tamoxifen-inducible version of the Cre recombinase (UbCre) (Ruzankina et al., 
2007). Cre activation and the subsequent deletion of the Pold3lox allele in adult 
mice was accomplished by supplementing the diet with 4-hydroxy-tamoxifen (4-
OHT), starting at 5 weeks of age (weaning).  This strategy has previously 
enabled the deletion of other essential genes, such as the SMC5/6 complex 
member Nsmce2 or Atr, which in both cases led to premature ageing but with 
mice surviving for up to 1 or 2 years of 4-OHT treatment, respectively (Jacome 
et al., 2015; Ruzankina et al., 2007). In striking contrast, UbCre/Pold3lox/lox mice 
started to show symptoms of severe distress only days after starting the diet 
and all died within 15 weeks (Figure 2A). These effects were dependent on 
Pold3 deletion, as they were not observed in Pold3lox/lox mice lacking the UbCre 
gene or in UbCre/Pold3+/+ mice, all of which were administered the same 4-OHT-
containing diet. 
 
To determine the efficiency of Pold3 deletion, we monitored POLD3 protein 
levels by western blotting (WB) in organs from UbCre/Pold3lox/lox and control mice 
fed for 1 month with the tamoxifen-containing diet (Figure 2B). 4-OHT induced 
a significant depletion of POLD3 in the lung, kidney and liver. In contrast, no 
clear reduction was observed in the spleen, consistent with previous studies 
targeting essential genes in adult mice (Jacome et al., 2015; Ruzankina et al., 
2007) and which can be explained by the selection for cells that did not undergo 
Cre-mediated recombination in organs with a high turnover rate. Next, to 
determine whether Pold3 deletion led to RS, we performed an 
POLD3 deficient mice   
   
Murga et al., submitted to Molecular Cell  7 
immunohistochemical analysis for phosphorylated histone H2AX (γH2AX), a 
marker of DNA damage and RS. In all organs tested, Pold3 deletion led to the 
widespread accumulation of cells with pan-nuclear γH2AX staining, indicative of 
RS (Figure 2C,D). This overall accumulation of DNA damage was associated 
with a noticeable decrease in tissue cellularity, as shown, for example, for the 
lungs (Figure 2D). In summary, Pold3 deletion in adult mice a generalized 
accumulation of DNA damage, leading to a severe pathology and ultimately the 
death of the animal. 
 
POLD3 is essential for DNA replication in B cells 
As noted above, we did not observe a decrease in POLD3 protein levels in 
the spleens of UbCre/Pold3lox/lox mice treated with 4-OHT, suggesting that the 
spleen is quickly replenished by cells that retained intact Pold3 alleles. To 
specifically investigate the role of POLD3 in splenic lymphocytes, we crossed 
Pold3lox/lox mice with a CD19Cre knock-in strain that drives the deletion of the 
floxed alleles in B cells (Rickert et al., 1997). Compared to wild-type (wt) or 
CD19Cre-negative Pold3lox/lox B cells, Pold3-deleted B cells showed very limited 
expansion following stimulation with lipopolysaccharide in vitro (Figure 3A), 
which correlated with a significant reduction in DNA replication in CD19Cre-
positive Pold3lox/lox B cells, as measured by BrdU incorporation (Figure 3B).  
 
We next explored whether deletion of Pold3 in CD19Cre-positive Pold3lox/lox B 
cells led to RS and genomic instability, using wt, CD19Cre-negative Pold3lox/lox 
and CD19Cre-positive Pold3+/+ cells as controls. Indeed, by western blotting, we 
observed higher levels of H2AX and CHK1 phosphorylation in the CD19Cre-
positive Pold3lox/lox B cells (Figure S1A), as well as decreased cell viability in 
response to inhibition of the RS-response kinase ATR (Figure S1B). Moreover, 
analysis of metaphase chromosomes from Pold3-deleted B cells revealed 
evidences of genomic instability, such as chromosome and chromatid breaks, 
cruciform structures and, most frequently, gaps indicative of incomplete DNA 
replication (Figure 3C,D). Finally, to directly evaluate DNA replication, we 
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performed analyses on stretched DNA fibers. These experiments revealed that 
POLD3-deficiency led to a slower progression of replication forks (Figure 3E 
and S1C) and demonstrated the presence of RS, as evidenced by a significant 
increase in fork stalling and asymmetry (Figure 3F and S1D-F). Importantly, the 
slower rates were confirmed in origin-driven forks; i.e. forks progressing around 
newly fired origins (“green-red-green” tracks) or in two proximal “red-green” 
tracks moving in opposite directions within the same fiber, as these forks are 
less likely to arise from BIR or repair-related processes (Figure S1C). 
Collectively, these results reveal that POLD3 is essential to sustain overall DNA 
replication during S phase and to suppress RS in B cells. 
 
POLD3 is haploinsufficient for stabilizing the Polδ  complex 
To determine the mechanism by which POLD3 is essential in mammalian 
cells we immunoprecipitated POLD3 from nuclear extracts of wt and Pold3-
deleted B lymphocytes, and subjected the precipitates to Mass Spectrometry 
(MS) (Table S1). Ranking the immunoprecipitated proteins by the difference in 
their abundance between wt and POLD3-deficient extracts, led to POLD1 and 
POLD2 ranking first from the entire list, whereas POLD4 ranked seventh. This 
not only validated the POLD3 immunoprecipitation (since it efficiently pulled 
down the whole Polδ complex), but also revealed that in addition to POLD3 all 
other members of the Polδ complex (POLD1, POLD2 and POLD4) were present 
at reduced levels in extracts lacking POLD3. Western blotting confirmed the 
overall low levels of POLD1-3 in POLD3-deficient B lymphocytes, while levels of 
the POLE subunit from the leading strand polymerase complex Polε remained 
unaltered (Figure 4A, see also Figure S2). Of note, and as mentioned above 
when deleting Pold3 in adult tissues, the reduction of POLD1-3 levels found in 
POLD3 deficient B-lymphocytes is likely more severe than observed due to the 
selection for wt cells that escaped Cre-mediated recombination. Accordingly, 
the reduction of POLD1-3 levels is more severe in slowly proliferating cell types 
such as mouse embryonic fibroblasts (MEFs) (see below).  
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Next, and given the phenotypes observed in Pold3 heterozygous mice, we 
analyzed B cell extracts from wt and Pold3+/- mice. These experiments revealed 
lower levels of POLD3, but also of the catalytic subunit POLD1 in Pold3 
heterozygous B cells (Figure 4B). To determine whether the partial reduction in 
POLD1 found in Pold3+/- cells had functional consequences we evaluated the 
impact of the DNA polymerase inhibitor aphidicolin (APH) in wt and Pold3 
heterozygous cells. Since the dose of a chemical inhibitor needed to inhibit its 
target correlates with the levels of the target protein, we reasoned that the lower 
levels of the catalytic subunit POLD1 could increase the sensitivity of Pold3 
heterozygous cells to APH. Indeed, FACS analyses showed that whereas 
overall DNA replication rates were similar in both cell types, a low dose of APH 
had a bigger impact in reducing BrdU incorporation rates in Pold3 heterozygous 
cells (Figure 4C). In addition, analyses of fork rate progression in stretched 
DNA fibers confirmed a higher sensitivity of Pold3+/- cells to APH (Figure 4D). 
Altogether, these data reveal that POLD3 is haploinsufficient for stabilizing the 
Polδ complex, which could explain the severe effects of its deficiency in 
mammalian cells. 
 
POLD3 deficiency sensitizes MEFs to oncogene expression 
To extend our findings to other cell types and to explore the impact of Pold3 
deletion in the context of oncogenes, we generated mouse embryonic 
fibroblasts (MEFs) from UbCre/Pold3lox/lox mice. Treatment of these MEFs with 4-
OHT led to the depletion of POLD3, POLD1 and POLD2 (with no effect on 
POLE) in all cellular compartments analysed (cytoplasm, nucleus and 
chromatin) (Figure S2A). Moreover, a 2-day treatment with 4-OHT led to a 
partial reduction in BrdU incorporation rates and slower S-phase progression 
UbCre/Pold3lox/lox mice (Figure S2B). Since residual POLD3 protein levels could 
explain the partial reduction in DNA replication observed upon a 2-day 4-OHT 
treatment, we took two independent approaches to further reduce POLD3. First, 
we exposed UbCre/Pold3lox/lox MEFs for up to 7 days of continuous 4-OHT 
treatment. This experiment revealed a progressive reduction in POLD1, POLD2 
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and POLD3 levels, which correlated with a stepwise decrease in DNA 
replication rates (measured by EdU incorporation) in these cells (Figure 
S2C,D). In addition to this experiment, UbCre/Pold3lox/lox MEFs were serum-
starved in the presence of 4-OHT for 72 hrs and subsequently released in the 
presence of serum. This approach further reduced POLD1-3 levels, and 
revealed a severe deficiency of Pold3-deleted cells in completing DNA 
replication with a concomitant accumulation of cells in S phase (Figure 4E,F). 
In order to evaluate the impact of POLD3 deficiency in the context of 
oncogenes, we first needed to define a faster way to deplete the protein. As an 
alternative way of depleting POLD3 in asynchronous cultures, we infected 
Pold3lox/lox MEFs with adenoviruses expressing Cre (AdCre), which is more 
efficient than the 4-OHT treatment. Consistent with our observations with the 
UbCre allele, exposure to AdCre led to a severe reduction in DNA replication in 
Pold3lox/lox MEFs, together with an accumulation of γH2AX as measured by 
High-Throughput Microscopy (HTM), which was aggravated by the expression 
of RASG12V or MYC oncogenes (Figure S3A,B). Moreover, while expression of 
RASG12V together with E1A oncogenes transforms primary MEFs, it was highly 
toxic in the context of POLD3-deficient MEFs (Figure S3C). Of note, we were 
unable to obtain any RASG12V/E1A-transformed clones lacking POLD3 
expression, suggesting that oncogenic transformation does not bypass the 











POLD3 deficient mice   
   
Murga et al., submitted to Molecular Cell  11 
DISCUSSION 
Recent studies have indicated a unique role for POLD3 in DNA synthesis 
occurring during the repair of RS-induced DNA breaks (Costantino et al., 2014; 
Mayle et al., 2015; Minocherhomji et al., 2015). Given that oncogene-induced 
RS is a major cause of genomic instability in cancer, targeting POLD3 could 
thus offer an opportunity to preferentially target cancer cells. While our research 
confirms that POLD3 deficiency is particularly toxic for cells expressing 
oncogenes, it has also identified a haploinsufficient role of Pold3 in stabilizing 
the Polδ complex and in safeguarding genomic integrity during DNA replication 
during S phase. Nevertheless, and besides the role of POLD3 in origin-
associated DNA synthesis, other functions of POLD3 in BIR or TLS could also 
contribute to the dramatic phenotypes observed upon Pold3 deletion in mice. 
The role of POLD3 in TLS has been mostly associated as being an integral 
member of the TLS-specific DNA polymerase zeta (Polζ) complex (Johnson et 
al., 2015; Makarova et al., 2012). In this regard, our proteomic analysis in B 
cells did not show changes on members of the Polζ complex in POLD3 deficient 
cells (Table S1), although the constitutive levels of this complex might be low in 
the absence of sufficient lesions that need to be dealt by TLS. Interestingly, 
recent work in chicken DT40 cells has revealed that POLD3 could also operate 
in TLS independently of Polζ and as part of the Polδ complex (Hirota et al., 
2016; Hirota et al., 2015), a function that could in principle be conserved in 
mammals. Nevertheless, and given the severe defects of Pold3 nullyzygosity in 
overall DNA replication, alternative genetic approaches will be needed to 
perform a dedicated analysis of the roles of POLD3 in BIR or TLS in mammalian 
cells.  In what regards to the idea of targeting POLD3 as a way to preferentially 
kill cancer cells, our results predict a broad deleterious effect of POLD3 
inhibition although the phenotypes of depleting versus inhibiting a protein are 
often not the same. The identification of separation of function mutants with 
impaired repair-associated DNA synthesis, but with an intact origin-linked DNA 
replication function (if these functions of POLD3 can be separated), should be 
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EXPERIMENTAL PROCEDURES 
Mouse models  
For the generation of Pold3 mutant mice, a linearized construct targeting Pold3 
(EUCOMM) was electroporated into ES cells. Upon identification of properly 
recombined ES clones, these were used for the generation of chimaeras using 
standard procedures. CD19Cre, UbCre, EIIA-Cre and actin-FLP strains have been 
described before (Lakso et al., 1996; Rickert et al., 1997; Rodriguez et al., 2000; 
Ruzankina et al., 2007). Mice were kept under standard conditions at specific-
pathogen free facility of the Spanish National Cancer Centre in a mixed 
C57BL/6-129/Sv background. All mouse work was performed in accordance 
with the Guidelines for Humane Endpoints for Animals Used in Biomedical 
Research, and under the supervision of the Ethics Committee for Animal 
Research of the “Instituto de Salud Carlos III”. 
 
DNA fiber analyses 
The analysis of stretched DNA fibers was performed as described before 
(Jacome et al., 2015). Briefly, B cell cultures were pulse-labeled with 50 µM 
CldU  (20 min) followed by 250 µM IdU (20 min). Labeled cells were collected 
and DNA fibers were spread in buffer containing 0.5% SDS, 200 mM Tris pH 
7.4 and 50 mM EDTA. For immunodetection of labeled tracks, fibers were 
incubated with primary antibodies against CldU and BrdU and developed with 
the corresponding secondary antibodies conjugated to Alexa dyes. A mouse 
anti-ssDNA antibody was used to assess fiber integrity.  
 
POLD3 immunoprecipipation 
500 µg of nuclear extracts from B cells were immunoprecipitated with Protein-G 
Dynabeads that were previously coated with an anti-POLD3 antibody (Sigma). 
Proteins were eluted in 8M urea in 0.1M triethylammonium bicarbonate, and 
digested with trypsin for subsequent analyses. Proteomics was performed by 
NanoLC-MS/MS using an LTQ-Orbitrap Velos (Thermo Scientific) coupled to a 
nanoLC Ultra system (Eksigent), equipped with a nanoelecroespray ion source 
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(Proxeon Biosystems). Raw data was processed using Proteome Discoverer 
1.4 (Thermo) and filtered for frequent contaminants.  
 
See the Supplemental Information for a full list of antibodies, as well as other 
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FIGURE LEGENDS 
Figure 1. POLD3 is essential for mouse development.  
(A) Scheme illustrating the targeting construct used for the generation of Pold3 
mutant mice (top), and how the Pold3lox and Pold3- alleles are obtained upon 
recombination with Flp or Cre recombinases, respectively. 
(B) Southern blot illustrating the presence of ES clones harboring the correct 
integration of the Pold3GT:lox allele that were subsequently used for the 
generation of mutant mice. The 10.2 Kb band corresponds to the endogenous 
Pold3 gene, and the 6.5 Kb band to the targeted allele. 
(C) Table representing the genotypes observed from inter-crossing Pold3 
heterozygous mice. The expected values are those estimated from the offspring 
of a homozygous-lethal cross. Only 62% (185/298) of the expected Pold3+/- 
mice are born.  
(D) Kaplan-Meyer curves of Pold3+/+ (n = 149) and Pold3+/- (n = 185) mice. The 
p value was calculated with the Mantel-Cox log rank test.  ***P<0.001.  
(E) Representative pictures of 2 month-old Pold3+/+ and Pold3+/- littermate mice 
illustrating the enlarged head morphology (red arrow) and overall dwarfism 
found in a subset of Pold3 heterozygous mice.  
(F) Brain sections of Pold3+/+ and Pold3+/- mice. Note that the forebrain (red 
arrow) is almost inexistent on Pold3 heterozygous brain (dashed lines). The 
skull cavity of the mutant mouse was found full of liquid upon necropsy. 
 
Figure 2. Pold3 deletion is severely toxic in adult mice.  
(A) Kaplan-Meyer curves of mice from the indicated genotypes that were 
exposed to a 4-OHT containing diet that started at week 5. The p value was 
calculated with the Mantel-Cox log rank test.  ***P<0.001.  
(B) WB illustrating the depletion of POLD3 levels that is observed on organs 
from UbCre/Pold3lox/lox mice fed the 4-OHT diet for 1 month. Note that no 
reduction in POLD3 levels is observed in the spleen.  
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(C,D) γH2AX immunohistochemistry from the liver (C) and lung (D) of Pold3lox/lox 
and UbCre/Pold3lox/lox mice fed the 4-OHT diet for 1 month. H/E: 
Hematoxylin/Eosin. Scale bar (black) indicates 200 µm. 
 
Figure 3. POLD3 sustains DNA replication and prevents RS in B cells.  
(A) Number of cells after stimulating 2.5x105 freshly isolated splenic B-
lymphocytes for 72 hrs with LPS. Dashed lines indicate mean values. **P<0.01; 
***P<0.001.  
(B) FACS analysis of DNA content (propidium iodide, PI) versus 5’-bromo-2’-
deoxyuridine (BrdU) incorporation in Pold3lox/lox and CD19Cre/Pold3lox/lox B cells, 
48 hrs after stimulation with LPS (25 µg/ml). BrdU was used at 10µM for 30 min. 
(C) Chromosomal abnormalities found per metaphase in B cells of the indicated 
genotypes 2 days after stimulation with LPS (25 µg/ml). Dashed lines indicate 
mean values. ***P<0.001.  
(D) Distribution of the different types of chromosomal rearrangements observed 
in metaphases from CD19Cre/Pold3lox/lox B cells.  
(E) Fork rates were measured in stretched DNA fibers (see Methods) prepared 
from B cells of the indicated genotypes. Data are representative of three 
indicative experiments. Approximately 900 tracks were measured to estimate 
fork rates. ***P<0.001.  
(F) Fork asymmetry (represented as left vs right fork lengths) in DNA fibers 
prepared from B cells of the indicated genotypes. The determination coefficient 
is indicated in blue (R2).  
See also Figure S1. 
 
Figure 4. POLD3 maintains the stability of the POLD complex.  
(A) WB illustrating the levels of POLD1, POLD2, POLD3 and POLE in B cell 
cultures from the indicated genotypes, 48 hrs after stimulation with LPS (25 
µg/ml). CDK2 was used as a loading control.  
(B) WB of POLD1, POLD3 and POLE levels from Pold3+/+ and Pold3+/- B cells. 
TUBULIN is shown as a loading control.  
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(C) Representative FACS analysis of DNA content (PI) versus BrdU 
incorporation in Pold3+/+ and Pold3+/- B cells. 48 hrs after stimulation with LPS 
(25 µg/ml) cells were exposed (or not) to 0.5 µM aphidicolin (APH) for 4 hrs, and 
then to BrdU (10µM) for another 30 min. Note that the APH treatment had a 
bigger impact on in limiting DNA replication on Pold3 heterozygous cells. 
(D) Fork rates were measured in stretched DNA fibers prepared from B cells of 
the indicated genotypes treated as in (C). Data from two independent B cell 
cultures of each genotype are shown. Approximately 300 tracks were measured 
to estimate fork rates in each condition. ***P<0.001.  
(E) WB illustrating the levels of POLD1, POLD2 and POLD3 in UbCre/Pold3lox/lox 
MEF exposed (or not) to 4-OHT (1 µM) and that were serum starved (0.1% 
serum) for 72 hrs and subsequently released in 15% serum-containing media 
for 24 hrs.  
(F) FACS analyses of DNA content (PI) from UbCre/Pold3lox/lox MEF exposed (or 
not) to 4-OHT (1 µM) and that were serum starved (0.1% serum) for 72 hrs and 
subsequently released in 15% serum-containing media for the indicated times. 
In (E) and (F) 4-OHT was present throughout the entire experiment where 
indicated. 
See also Figures S2, S3 and Table S1. 
 
 
 




